Abstract:Small molecule ligands that can specifically recognize the surface of cancer cells have wide utilities in cancer diagnosis and treatment. Screening large combinatorial libraries against live cells is an effective approach to discover cell-targeting ligands. In the past decade, DNA-encoded chemical library (DEL or DECL) has become a powerful technology in drug discovery and been successfully used in ligand discovery against numerous biological targets. However, nearly all DEL selections had predefined targets, whereas completely unbiased DEL selections interrogating the entire cell surface remain underexplored. In this report, we systematically optimized cell-based DEL selection method to perform unbiased selections against cancer cells without predefined targets. A 104.96-million-member DEL was selected against MDA-MB-231 and MCF7, a pair of breast cancer cell lines with high and low metastatic properties, respectively, and cell-specific small molecule ligands and ligand combinations (“clusters”) have been identified. We further show that the ligand cluster could be optimized to improve the binding affinity and applied in cell-targeting applications including cancer photodynamic therapy and targeted drug delivery. Finally, we leveraged the DNA tag of the DEL compounds and identified the cell surface receptor of an individual ligand targeting MDA-MB-231 cells. Overall, this work provides an efficient method for discovering cell-targeting small molecules and demonstrated the potential of DELs as a tool for cancer biomarker discovery.

Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach

Identification and Validation of WDR5 WIN-site Ligands Via DNA-encoded Chemical Library Screening

Selection of DNA‐Encoded Dynamic Chemical Libraries for Direct Inhibitor Discovery

ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

Future challenges with DNA-encoded chemical libraries in the drug discovery domain.

Highly Selective Novel Heme Oxygenase-1-Targeting Molecules Discovered by DNA-Encoded Library-Machine Learning Model beyond the DEL Chemical Space

Quantitative Validation and Application of the Photo-Cross-Linking Selection for Double-Stranded DNA-Encoded Libraries

Development of a DNA-encoded library screening method DEL Zipper to empower the study of RNA-targeted chemical matter

Dna-Encoded Dynamic Chemical Library And Its Applications In Ligand Discovery

Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library

Discovery, SAR Study of GST Inhibitors from a Novel Quinazolin-4(1H)-one Focused DNA-Encoded Library

Chemical Space Profiling of SARS-CoV-2 PL pro Using DNA-Encoded Focused Libraries

Discovery, SAR Study of GST Inhibitors from a Novel Quinazolin-4(1 H )-one Focused DNA-Encoded Library

Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding

Highly Selective Novel Heme Oxygenase-1 Hits Found by DNA-Encoded Library Machine Learning beyond the DEL Chemical Space

Covalent Capture and Selection of DNA-Encoded Chemical Libraries via Photo-Activated Lysine-Selective Crosslinkers

Abstract 3091: Discovery of highly selective ligands with unique binding modes for challenging oncology targets using DNA-encoded chemical libraries

Discovering Cell-targeting Ligands and the Cell Surface Receptors via Selection of DNA-encoded Chemical Libraries (DELs) against Cancer Cells without Predefined Targets

Selecting a DNA-Encoded Chemical Library Against Non-immobilized Proteins Using a “Ligate–cross-Link–purify” Strategy

DNA-Encoded Library Technology─A Catalyst for Covalent Ligand Discovery